(Q44871848)

English

The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial

scientific article published on 3 February 2014

Statements

The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial (English)
0 references
Carlota Costa
Jordi Bertran-Alamillo
Mayumi Ono
Petros Giannikopoulos
3 February 2014
2001-2010

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit